MAPT and Alzheimer disease: GSK-3β has also been implicated in AD, whereas the increased activity of GSK-3β that leads to hyperphosphorylation of tau protein which can promote neurogenesis, impaired synaptic plasticity apoptosis, and hyperexcitability in the hippocampus.